UNSPSC 51145001: Linopirdine
Commodity
Code facts
- Part of
-
-
51000000
-
51140000
- 51145000
-
51140000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51145001
Definition
This classification denotes a cation channel blocker with the molecular formula C26H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) I5TB3NZ94T, chemically known as 1,3-dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2h-indol-2-one but more generally known as linopirdine, which bears US NIH Compound Identifier 3932. European Medicines Agency schedules Linopirdine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08522MIG.
Read the full definition
The term LINOPIRDINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules linopirdine in its Anatomical Therapeutic Chemical (ATC) Classification. LINOPIRDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule linopirdine under HS 29337900 and SITC 51561. As of Q4 2014, LINOPIRDINE remains US FDA's Preferred Term for this commodity.
Linopirdine bears US NLM identifiers UMLS ID C0286263 and NCI Concept Code C82306. SMILES: O=C1N(C2C(C1(CC1CCNCC1)CC1CCNCC1)CCCC2)C1CCCCC1.
About UNSPSC 51145001
UNSPSC 51145001 Linopirdine is a Commodity code that in practice covers pharmaceutical procurement by state and local health agencies, though the recent opportunity record shows a mismatch between the code's nominal scope and actual buying patterns. Seminole County, Florida posted an IFB in mid-2026 for naloxone and drug deactivation systems—opioid-reversal medications and related harm-reduction equipment—rather than linopirdine itself, suggesting that state and local procurement offices may tag broader pharmaceutical-procurement activities under this code irregularly or that the code's application has drifted from its original scope. The work being solicited includes annual supply contracts with quarterly delivery schedules, fixed pricing, and compliance requirements including drug-free workplace certification, E-Verify validation, and in some cases federal compliance obligations such as the Clean Air Act and Federal Water Pollution Control Act.
The geographic record is thin. Seminole County, Florida represents the only recent documented opportunity under this code in the dataset. The county health department issued the IFB (IFB60459723LAS) on June 30, 2026, with a response deadline of July 26, 2023—a date discrepancy in the source itself that creates uncertainty about the actual procurement timeline. The contract specifies quarterly deliveries of 1,900 units of naloxone and 800 drug deactivation systems annually to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year term plus an optional one-year renewal. No set-aside designations were noted, and vendors were required to include all shipping and delivery costs in their bids. Without additional recent opportunities in other jurisdictions, the code shows limited documented activity in the state and local sector.
Quick answers
What is UNSPSC 51145001?
UNSPSC 51145001 is Linopirdine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51145001?
UNSPSC 51145001 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51145001
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code